101.40MMarket Cap
LossP/E TTM
ImmuCell Corp's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of ImmuCell Corp is 7.37, ranking 106 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -181.69, which is -118.64% below the recent high of 33.88 and -4.55% above the recent low of -189.95.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.